You are terrified.
100% of EMD AML patients responded to Bisantrene in 2020. 40% of patients responded to Bis/Clo/Flu with 0 cardiac events in 2023.
You loved the AraC Losartan preclinical data, right? Clofarabine and Fludarabine are antimetabolites like AraC, but they are rated severely cardiotoxic by the FDA. This circumstanitally proves CPACS, as well as validates all the history for Bisantrene.
You are terrified of this data, which is why you don't talk about it.
Cardioprotection thread, page-748
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.56 |
Change
0.010(0.65%) |
Mkt cap ! $265.8M | |||
| Open | High | Low | Value | Volume |
| $1.55 | $1.56 | $1.51 | $95.69K | 62.25K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3015 | $1.55 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.56 | 4018 | 1 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |